Poland· PL-100450611
Tadomon
A tapentadol product containing tapentadolum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tapentadol is registered in 17 of 19 countries.
Countries holding a registration under ATC N02AX06 (tapentadol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Tapentadol · ATC N02AX06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tapentadol costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $2.14 in Italy to $6.62 in Switzerland — a ×3.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tapentadol · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.62
- ES Spain$3.34
- IT Italy$2.14
The record
At a glance
URPL (Poland)- Active substance
- Tapentadolum
- Manufacturer
- G.L. Pharma GmbH
- Country
- Poland (PL)
- ATC code
- N02AX06
- ATC class
- Tapentadol
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 12
1 priced- gtin0900873201772460 szt.PLN 296.44
- gtin09008732017717
- gtin08436046015371
- gtin08436046015258
- gtin08436046015319
- gtin08436046015197
- gtin08436046015432
- gtin05909991535230
- gtin09008732017694
- gtin09008732017700
- gtin09008732017731
- gtin09008732017687
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
184 interactions on record for tapentadol.
Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tapentadol · interactions on record
184 records
- 30 severe
- 130 moderate
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tapentadol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMABINOVANSandoz s.r.o., Praha
- United KingdomAtiondo SR 200mg tabletsGrunenthal Ltd
- SpainPALEXIA RETARD 200 mg COMPRIMIDOS DE LIBERACION PROLONGADAGrünenthal Pharma S.A.
- SwedenPalexia Depot 200 mg DepottablettGrünenthal GmbH
- NetherlandsPalexia Retard 200 mg tabletten met verlengde afgifteGrünenthal B.V.
- IrelandPalexia SR 200 mg prolonged-release tabletsGrunenthal Pharma Limited.
- BelgiumPalexia Retard 200 mgGrunenthal
- ItalyPALEXIAGRUNENTHAL ITALIA S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Palexia, Palexia Retard
- Belgium · Palexia, Palexia Retard
- Cyprus · Dolten, Dolten Retard
- Czechia · Apeneta, Dolupren
- Germany · Palexia, Palexia Akutschmerz
- Denmark · Palexia, Palexia Depot
- Estonia · Tapemed Retard
- Spain · Palexia, Palexia Retard
- United Kingdom (Northern Ireland) · Ationdo, Ationdo Sr
- Greece · Dolupren, Dolupren Ir
- Croatia · Apeneta, Dolten
- Hungary · Adoben
- Ireland · Apeneta, Palexia
- Iceland · Tapentadol Stada
- Italy · Palexia, Taboxea
- Luxembourg · Palexia, Palexia Retard
- Malta · Dolten, Dolten Retard
- Netherlands · Palexia, Palexia Retard
- Norway · Palexia, Palexia Depot
- Portugal · Ationdo, Palexia
- Romania · Dolten
- Sweden · Palexia, Palexia Depot
- Slovenia · Apeneta, Palexia
- Slovakia · Apeneta, Dolten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb2c5ebf-8ba1-4fd8-a868-a44d46e3b436 GET /v1/drugs/fb2c5ebf-8ba1-4fd8-a868-a44d46e3b436?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki o przedłużonym uwalnianiu",
"source": "urpl",
"strength": "200 mg",
"packaging": "08436046015371 ¦ Rpw ¦ Skasowane ¦ 146795\n60 tabl.\n08436046015258 ¦ Rpw ¦ Skasowane ¦ 146796\n28 tabl.\n08436046015319 ¦ Rpw ¦ Skasowane ¦ 146797\n30 tabl.\n08436046015197 ¦ Rpw ¦ Skasowane ¦ 146798\n7 tabl.\n08436046015432 ¦ Rpw ¦ Skasowane ¦ 146799\n100 tabl.\n05909991535230 ¦ Rpw ¦ Skasowane ¦ 153770\n40 tabl.\n09008732017717 ¦ Rpw ¦ 157021\n40 tabl.\n09008732017694 ¦ Rpw ¦ 157022\n28 tabl.\n09008732017700 ¦ Rpw ¦ 157023\n30 tabl.\n09008732017724 ¦ Rpw ¦ 157024\n60 tabl.\n09008732017731 ¦ Rpw ¦ 157025\n100 tabl.\n09008732017687 ¦ Rpw ¦ 157026\n7 tabl.",
"substance": "Tapentadoli tartras 335.62 mg",
"common_name": "Tapentadolum",
"pl_product_id": "100450611",
"pozwolenie_nr": "27339",
"auth_procedure": "DCP",
"authorisation_validity": "2027-09-07"
}See everything about tapentadol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.